A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...

Recent research indicates that colon cancer patients with circulating tumor DNA post-surgery may improve their survival likelihood with daily celecoxib use. Celecoxib, a COX-2 inhibitor, significantly ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...

It's more expensive. Sold only as a prescription, brand-name drug, celecoxib can easily cost $130 or more a month for a standard dose, compared with about $25 for the generic, over-the-counter ...

The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the agency since 1998.

[1] A case of this drug reaction from celecoxib is reported. A 61-year-old nonatopic woman presented with 15 round, red-brown, edematous, moderately itching patches. Their size varied from 2 to 10 ...

A recent analysis from a randomized clinical trial conducted by researchers at the Dana-Farber Brigham Cancer Center ...

Vertex Pharmaceuticals Inc. (VRTX) has secured FDA approval for Suzetrigine, an oral, non-opioid, highly selective NaV1.8 pain signal ...

Celebrex (celecoxib) and ibuprofen are both ... with a history of stomach ulcers or sensitivities to other NSAIDs. The drug's ...

The Alliance for Clinical Trials in Oncology today announced the results of a data analysis from a randomized phase III clinical trial involving patients with stage III colon cancer, which found that ...